CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 1.240
- -0.020-1.59%
Trading Apr 30 10:04 ET
56.29MMarket Cap-1.20P/E (TTM)
1.255High1.200Low36.99KVolume1.240Open1.260Pre Close45.26KTurnover0.08%Turnover RatioLossP/E (Static)45.40MShares4.42052wk High2.96P/B54.54MFloat Cap0.85152wk Low--Dividend TTM43.98MShs Float17.850Historical High--Div YieldTTM4.37%Amplitude0.615Historical Low1.223Avg Price1Lot Size
PDS Biotechnology Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4.14%-35.03M | 2.63%-8.23M | -11.48%-8M | -83.99%-8.86M | 24.65%-9.94M | -30.83%-33.64M | -12.33%-8.46M | -21.77%-7.18M | 18.66%-4.81M | -107.08%-13.19M |
| Net income from continuing operations | 12.42%-37.61M | 27.03%-7.95M | 1.13%-10.73M | 27.80%-8.33M | -9.77%-10.6M | -5.11%-42.94M | 43.05%-10.9M | -46.13%-10.85M | -98.22%-11.53M | -14.00%-9.66M |
| Depreciation and amortization | 21.62%21.11K | 15.27%5.46K | 15.36%5.46K | 15.27%5.46K | 50.08%4.74K | 20,084.88%17.36K | --4.74K | --4.73K | --4.74K | 3,568.60%3.16K |
| Other non cash items | -21.94%1.46M | -54.84%307.44K | 51.17%314.8K | -29.19%560.44K | 44.87%279.91K | -65.77%1.87M | -86.87%680.76K | 22.21%208.24K | 1,213.46%791.45K | 220.64%193.21K |
| Change In working capital | -2,786.31%-5.75M | -658.83%-2.24M | -54.68%628.44K | -175.72%-2.89M | 78.48%-1.25M | -104.45%-199.28K | -92.07%400.69K | 8,154.92%1.39M | 353.15%3.82M | -734.33%-5.81M |
| -Change in prepaid assets | -625.31%-870.29K | -1,165.02%-984.79K | -65.67%47.69K | -883.69%-376.4K | 489.61%443.21K | 115.59%165.67K | -14.91%92.47K | 1,363.49%138.93K | 105.29%48.03K | 54.83%-113.76K |
| -Change in payables and accrued expense | -3,790.24%-4.88M | -506.97%-1.25M | -55.60%580.75K | -165.15%-2.52M | 69.79%-1.69M | -102.08%-125.48K | -93.92%308.23K | 359.00%1.31M | 833.62%3.86M | -562.99%-5.6M |
| -Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | -222.03%-239.47K | --0 | -222.38%-60.33K | -22.08%-90.03K | -107.04%-89.1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4.14%-35.03M | 2.63%-8.23M | -11.48%-8M | -83.99%-8.86M | 24.65%-9.94M | -30.83%-33.64M | -12.33%-8.46M | -21.77%-7.18M | 18.66%-4.81M | -107.08%-13.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -29K | 0 | -1 | 0 | 0 | 0 | ||||
| Net PPE purchase and sale | ---29K | --0 | ---1 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---29K | --0 | ---1 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 23.28%20.19M | -98.40%172.78K | -97.85%17.22K | -105.74%-13.79K | 338.11%20.01M | -52.24%16.38M | 10.92%10.77M | -96.73%802.33K | 970.07%240.01K | 60,902.34%4.57M |
| Net issuance payments of debt | -5,263.90%-3.18M | -23,735.92%-3.14M | -9.54%-14.11K | -9.53%-13.79K | 34.80%-13.48K | -100.24%-59.3K | ---13.17K | -100.05%-12.88K | ---12.59K | ---20.67K |
| Net common stock issuance | 40.11%22.6M | -69.77%3.17M | -108.24%-67.18K | --0 | 324.85%19.49M | 63.62%16.13M | 6.32%10.48M | --815.2K | --243.74K | --4.59M |
| Proceeds from stock option exercised by employees | 150.56%774.09K | -51.85%144.5K | --98.5K | --0 | --531.09K | 104.04%308.94K | 146.99%300.09K | --0 | -60.55%8.85K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 23.28%20.19M | -98.40%172.78K | -97.85%17.22K | -105.74%-13.79K | 338.11%20.01M | -52.24%16.38M | 10.92%10.77M | -96.73%802.33K | 970.07%240.01K | 60,902.34%4.57M |
| Net cash flow | ||||||||||
| Beginning cash position | -23.38%56.56M | -8.29%49.75M | -4.77%57.73M | 2.20%66.63M | -23.38%56.56M | 13.15%73.82M | -24.27%54.25M | 14.42%60.62M | 10.73%65.2M | 13.15%73.82M |
| Current changes in cash | 13.84%-14.87M | -449.12%-8.06M | -25.24%-7.98M | -94.58%-8.9M | 216.86%10.07M | -301.22%-17.26M | 6.03%2.31M | -134.16%-6.37M | 22.42%-4.57M | -35.51%-8.62M |
| End cash Position | -26.29%41.69M | -26.29%41.69M | -8.29%49.75M | -4.77%57.73M | 2.20%66.63M | -23.38%56.56M | -23.38%56.56M | -24.27%54.25M | 14.42%60.62M | 10.73%65.2M |
| Free cash flow | -4.23%-35.06M | 2.63%-8.23M | -11.48%-8M | -84.59%-8.89M | 24.65%-9.94M | -30.83%-33.64M | -12.33%-8.46M | -21.77%-7.18M | 18.66%-4.81M | -107.08%-13.19M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025